Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x100px

Product › Details

Tiapridal®

	Next higher product group	tiapride (INN)
	Status	1992-01-01 sales existent
	Status	1998-01-01 sales existent

Record changed: 2023-07-10

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Parkinson drug

[1] Merz Therapeutics GmbH. (7/10/24). "Press Release: Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics". Frankfurt a. M.....
[2] Merz Therapeutics GmbH. (4/2/24). "Press Release: Merz Enters Asset Purchase Agreement with a US-based Biotech Company". Frankfurt am Main....
[3] UCB S.A.. (12/2/21). "Press Release: UCB Announces Global Partnership to Bring Disease-modifying Therapies to People Living with Parkinson’s Disease". Brussels....
[4] AC Immune S.A.. (7/27/21). "Press Release: AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH". Lausanne....
[5] Newron Pharmaceuticals S.p.A.. (9/20/19). "Press Release: Newron Pharmaceutical Commercialization Partner Meiji Seika together with Eisai Announce the Approval of Safinamide for Parkinson’s Disease in Japan". Milan....
[6] Max Planck Society. (9/11/19). "Press Release: Max Planck Society Grants License for New Drug Candidates"....
[7] Modag GmbH. (9/4/19). "Press Release: Modag Appoints Dr. Johannes Levin as Chief Medical Officer". Wendelsheim....
[8] Modag GmbH. (6/27/19). "Press Release: Modag Launches Out of Stealth Mode with Series A Financing of EUR 12 Million to Develop Treatments for Parkinsonian Disorders, Including Multiple System Atrophy". Wendelsheim....
[9] Gain Therapeutics SA. (2/26/19). "Press Release: Gain Therapeutics SA Announces Award of Grant Support from Leading Parkinson’s Research Foundations to Advance Its Proprietary Non Competitive Molecular Chaperones for Parkinson’s Disease". Lugano & Bar...

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)